Gs. Cox et al., MSPI RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AT THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT LOCUS - ASSOCIATION OF CERTAIN GENOTYPES WITH NEOPLASIA, Biochimica et biophysica acta, N. Gene structure and expression, 1354(1), 1997, pp. 83-96
A restriction fragment length polymorphism (RFLP) in the human glycopr
otein hormone common a-subunit gene has been identified and partially
characterized in normal lymphocytes and placentae, established tumor c
ell lines, and tumor biopsy samples. High molecular weight DNA was dig
ested with the restriction endonuclease MspI, separated by electrophor
esis in agarose gels, transferred to nylon membranes by the method of
Southern, and hybridized to P-32-labeled human chorionic gonadotropin
alpha-subunit cDNA. After autoradiography, bands were detected at 5.3,
3.3, 2.1, 1.6, 0.8 and 0.6 kbp. Presence of the 5.3, 3.3 and 0.6 kbp
bands was invariant and uninformative. Patterns missing the 0.8 kbp ba
nd and both the 2.1 and 1.6 kbp bands are consistent with separate all
eles that occur in placental and lymphocyte DNA with frequencies of 0.
44 (15/34) and 0.06 (2/34), respectively. Presence of all three bands
(2.1, 1.6 and 0.8 kbp) is indicative of heterozygosity, occurring at a
frequency of 0.50 (17/34). Additional restriction patterns, not yet o
bserved in DNA isolated from term placentae or circulating lymphocytes
, were detected in DNA obtained from tumor cell lines and fresh tumor
tissues at frequencies of 0.79 (15/19) and 0.59 (10/17), respectively.
Thus, particular a-subunit genotypes are disproportionately represent
ed in tumor-derived DNA, occurring at frequencies 10- to 13-times high
er than would be predicted from their occurrence in normal tissue. Pai
red normal and tumor tissues from the same individual exhibited identi
cal hybridization patterns, suggesting that this RFLP may be represent
ative of a predisposition toward a variety of neoplasias rather than i
ndicative of a change in DNA structure at or near this locus as a resu
lt of tumor development. (C) 1997 Elsevier Science B.V.